D'Or Institute for Research and Education Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2020
NCT04480593
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

D'Or Institute for Research and Education

Active Ingredients

Drugs in Phase 4 Trials (1)

inactivated SARS-Cov-2 vaccine (1 trial)

Drugs in Phase 3 Trials (3)

brazilian green propolis extract (2 trials)

heparin (liquaemin) (1 trial)

methylprednisolone (medrol) (1 trial)

Drugs in Phase 2 Trials (4)

azd1222 (1 trial)

coronavac (1 trial)

COVID-19 convalescent plasma (2 trials)

scb-2019 (1 trial)

Drugs in Phase 1 Trials (1)

allogeneic bone marrow derived mesenchymal stem cell (1 trial)

Drugs in Other Trials (1)

mitoquinone (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pneumonia (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 10